Gain Therapeutics, Inc. Common Stock (GANX) Stock Price Today & Analysis

GANX
GANX company logo
Loading...
Chart by TradingView

Valuation

Market cap$82.43M
Price-to-sales ratioN/A
Price-to-book value4.41
Price-earnings ratio-4.10
Return on Equity-238.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A

Earnings Per Share

Earnings Per Share$-0.61

Income Statement

Average volume827,438
EBITDA$-19.21M
1 year high (52w)$4.34
1 year low (52w)$1.41

Dividend

Dividend yield0.00%

Solvency

Debt-to-equity ratioN/A

About Gain Therapeutics, Inc. Common Stock

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

FAQ

Buying Gain Therapeutics, Inc. Common Stock (GANX) stock is now easy and instant through the Gotrade app.
  1. Download the Gotrade app from the App Store or Google Play.
  2. Create an account and complete KYC.
  3. Make a deposit.
  4. Search for the code "GANX", then tap "Trade".
  5. Tap the "Buy" button.
  6. Enter the amount you want to buy. You have two options:
    1. Buy GANX by number of shares.
    2. Buy fractional shares in dollars, starting from $1.
  7. Swipe up to confirm your order—done!
On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in Gain Therapeutics, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.
At the moment, Gain Therapeutics, Inc. Common Stock (GANX) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track GANX's performance via the price chart in the Gotrade app.
Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).
You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours.
Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.
There's no single perfect answer, but common approaches include:
  • Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
  • Review revenue and earnings growth.
  • Check margins and cash flow.
  • Evaluate business outlook and the company's position within its industry.
You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Related news

AppLogo

Buy saham GANX
di Gotrade

AppLogo

Gotrade